middl
east
respiratori
syndrom
coronaviru
merscov
identifi
first
middl
east
respiratori
syndrom
mer
outbreak
merscov
caus
acut
lowerrespiratori
infect
human
fatal
rate
current
regist
vaccin
mean
therapeut
protect
mer
world
merscov
glycoprotein
play
import
role
viral
life
cycl
viru
intern
protein
immunodomin
antigen
main
target
neutral
antibodi
present
studi
immunogen
five
differ
form
merscov
glycoprotein
compar
fulllength
glycoprotein
fulllength
glycoprotein
transmembran
domain
g
glycoprotein
vsv
sg
receptorbind
domain
rbd
glycoprotein
membranefus
rbd
rbd
fuse
transmembran
domain
vsv
g
glycoprotein
rbdg
rbd
fuse
fc
human
rbdfc
recombin
vector
base
human
adenovirus
type
use
deliveri
vehicl
vaccin
develop
vector
elicit
balanc
respons
mice
robust
humor
immun
respons
induc
anim
vaccin
membranefus
rbd
immun
membran
form
glycoprotein
elicit
neutral
antibodi
among
vaccin
anim
signific
cellular
immun
respons
induc
vaccin
anim
fulllength
investig
suggest
fulllength
membran
form
rbd
rbdg
promis
vaccin
candid
among
studi
form
glycoprotein
keyword
middl
east
respiratori
syndrom
mer
merscov
glycoprotein
adenovir
vector
immun
abbrevi
ci
confid
interv
apc
allophycocyanin
dipeptidyl
peptidas
fc
fragment
crystalliz
ffu
focusform
unit
recombin
vector
base
adenoviru
type
rbd
receptorbind
domain
merscov
glycoprotein
rbdfc
receptorbind
domain
merscov
glycoprotein
fuse
fc
human
rbdg
receptorbind
domain
merscov
glycoprotein
fuse
transmembran
domain
vsv
g
glycoprotein
merscov
glycoprotein
domain
merscov
glycoprotein
sg
fulllength
glycoprotein
transmembran
domain
g
glycoprotein
vsv
th
helper
vsv
vesicular
stomat
viru
mer
middl
east
respiratori
syndrom
merscov
middl
east
respiratori
syndrom
coronaviru
pfu
plaqueform
unit
vp
viral
particl
gmt
geometr
mean
titer
interferon
gamma
tm
transmembran
domain
sar
sever
acut
respiratori
syndrom
sarscov
sever
acut
respiratori
syndrom
coronaviru
pbsphosphatebuff
salin
pbst
pb
supplement
tween
er
endoplasm
reticulum
middl
east
respiratori
syndrom
mer
acut
inflammatori
respiratori
infect
first
identifi
saudi
arabia
june
caus
agent
mer
offici
call
middl
east
respiratori
syndrom
coronaviru
merscov
merscov
singlestrand
rna
viru
belong
coronavirida
famili
genu
betacoronaviru
dromedari
camel
natur
reservoir
merscov
viral
transmiss
human
occur
consumpt
unpasteur
camel
milk
airborn
transmiss
also
possibl
date
total
laboratoryconfirm
case
merscov
infect
report
includ
death
due
high
mortal
rate
combin
wide
distribut
reservoir
absenc
effect
prevent
drug
treatment
expert
classifi
merscov
viru
potenti
caus
pandem
therefor
vaccin
develop
necessari
order
stave
pandem
main
protect
merscov
antigen
glycoprotein
present
trimer
viru
surfac
glycoprotein
play
import
role
viru
intern
cell
glycoprotein
subdivid
two
subunit
subunit
contain
receptorbind
domain
rbd
subunit
respons
fusion
viru
cell
membran
featur
make
protein
import
target
merscov
vaccin
develop
rbd
merscov
glycoprotein
key
target
develop
prevent
therapeut
mean
mer
rbd
mediat
interact
merscov
receptor
cell
surfac
order
develop
effect
merscov
vaccin
import
understand
form
glycoprotein
includ
vaccin
provid
protect
mer
data
demonstr
immunogen
variou
form
merscov
glycoprotein
howev
question
form
prefer
vaccin
remain
open
sinc
antigen
panel
test
condit
order
address
knowledg
gap
construct
five
recombin
vector
base
human
adenoviru
type
express
differ
form
merscov
glycoprotein
fulllength
glycoprotein
local
endoplasm
reticulum
er
two
secret
variant
receptor
bind
domain
merscov
glycoprotein
contain
alkalin
phosphatas
leader
peptid
rbd
rbd
fuse
fc
human
increas
stabil
immunogen
two
transmembran
tm
form
local
plasma
membran
cell
either
fulllength
rbd
tm
domain
vesicular
stomat
viru
vsv
g
glycoprotein
fulllength
glycoprotein
local
er
construct
sg
variant
delet
er
local
signal
chose
platform
base
recombin
viral
vector
deliv
glycoprotein
vector
effici
deliv
transgen
multipl
cell
type
genom
fulli
character
abl
grow
high
titer
induc
strong
humor
cellular
immun
respons
present
studi
compar
humor
cellular
immun
respons
induc
vaccin
mice
carri
differ
form
merscov
glycoprotein
cell
line
obtain
russian
collect
vertebr
cell
line
russia
vero
cell
obtain
atcc
usa
cell
cultur
dmem
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
co
merscov
glycoprotein
amino
acid
sequenc
strain
obtain
ncbi
databas
consensu
sequenc
merscov
glycoprotein
made
basi
amino
acid
sequenc
use
softwar
nucleotid
sequenc
differ
glycoprotein
form
optim
express
mammalian
cell
line
synthes
evrogen
jsc
russia
five
recombin
plasmid
gener
obtain
accord
procedur
describ
previous
cell
seed
cultur
petri
dish
cotransfect
three
plasmid
plvcmvegfp
pcmvmerscov
obtain
pseudovirus
seventytwo
hour
later
supernat
collect
filter
divid
aliquot
store
vero
cell
use
titrat
pseudovirus
titer
pseudotyp
viru
determin
term
focusform
unit
ffu
evalu
express
differ
form
merscov
glycoprotein
western
blot
cell
seed
mm
petri
dish
incub
overnight
confluenc
ad
cell
pfuscel
use
control
viru
h
express
differ
form
merscov
glycoprotein
evalu
western
blot
use
sspecif
antibodi
sino
biolog
china
antibodi
specif
rabbit
igg
ge
great
britain
express
membranefus
form
glycoprotein
sg
rbdg
detect
cell
lysat
prepar
use
cell
cultur
lysi
reagent
promega
usa
express
secret
version
glycoprotein
rbd
rbdfc
evalu
cultur
medium
lysat
sampl
load
onto
well
total
protein
volum
sampl
medium
load
volum
anim
experi
perform
strict
accord
recommend
nation
standard
russian
feder
gost
r
principl
good
laboratori
practic
sixweekold
femal
mice
g
obtain
pushchino
breed
facil
russia
mice
free
access
water
food
mice
hous
isocag
system
tecniplast
itali
mice
randomli
distribut
group
n
per
group
analysi
humor
immun
respons
n
per
group
analysi
tcell
respons
intramuscularli
vaccin
obtain
recombin
adenovir
particl
dose
vpmous
total
volum
ml
serum
specimen
collect
day
postvaccin
detect
sspecif
igg
antibodi
glycoproteinspecif
antibodi
titer
mous
serum
sampl
determin
enzymelink
immunosorb
assay
elisa
follow
recombin
protein
use
analysi
glycoprotein
sino
biolog
rbd
sino
biolog
nonspecif
antibodi
bind
site
block
pb
tween
pbst
contain
fatfre
milk
applichem
spain
serum
sampl
titrat
twofold
serial
dilut
pbst
contain
fatfre
milk
follow
antimous
igg
horseradish
peroxidaseconjug
secondari
antibodi
use
detect
total
igg
titer
ge
healthcar
usa
abcam
uk
abcam
uk
abcam
uk
abcam
uk
tetramethylbenzidin
solut
research
institut
organ
semiproduct
dye
russia
use
visual
reagent
reaction
stop
ad
h
optic
densiti
measur
nm
od
use
multiscan
fc
spectrophotometr
plate
reader
thermo
fisher
scientif
igg
titer
determin
maximum
serum
dilut
od
valu
serum
sampl
immun
anim
exceed
control
anim
serum
sampl
twofold
pseudovirionbas
neutral
assay
psvna
perform
describ
previous
briefli
heatinactiv
serum
sampl
dilut
sampl
mix
equal
volum
dmem
contain
ffusml
pseudovirion
mixtur
incub
h
inocul
onto
vero
cell
monolay
incub
h
number
egfp
fluoresc
cell
focus
count
pseudovirion
neutral
titer
serum
sampl
immun
anim
determin
maximum
dilut
reduct
egfp
fluoresc
cell
focus
compar
serum
sampl
intact
nonimmun
anim
determin
mice
euthan
day
postvaccin
spleen
collect
spleen
homogen
passag
siev
steril
pb
splenocyt
isol
ficol
gml
paneco
russia
densiti
gradient
centrifug
g
min
tcell
prolifer
assay
splenocyt
stain
carboxyfluorescein
use
succinimidyl
ester
cfse
tracer
kit
invitrogen
usa
accord
procedur
describ
previous
cell
seed
plate
cellswel
complet
medium
restimul
recombin
merscov
protein
sino
biolog
day
cell
harvest
wash
pb
stain
antibodi
specif
allophycocyanin
apc
label
phycoerythrinlabel
bd
bioscienc
usa
fix
paraformaldehyd
prolifer
lymphocyt
determin
cell
mixtur
use
bd
fac
aria
iii
flow
cytomet
bd
bioscienc
result
percentag
prolifer
cell
x
determin
use
formula
x
st
st
percentag
prolifer
cell
splenocyt
restimul
recombin
merscov
glycoprotein
percentag
prolifer
cell
absenc
splenocyt
restimul
intact
cell
splenocyt
isol
day
postvaccin
use
procedur
describ
cell
seed
plate
cellswel
medium
follow
restimul
recombin
merscov
sino
biolog
concentr
fortyeight
h
posttreat
cultur
supernat
collect
concentr
supernat
measur
elisa
use
commerci
kit
mous
elisa
kit
invitrogen
accord
manufactur
instruct
increas
concentr
determin
use
formula
x
cst
cint
x
fold
increas
concentr
cst
concentr
medium
stimul
cell
pgml
cint
concentr
medium
nonstimul
intact
cell
pgml
statist
analysi
perform
use
graphpad
softwar
graphpad
softwar
usa
analys
data
unpair
sampl
either
student
ttest
independ
sampl
mannwhitney
utest
use
depend
data
distribut
normal
distribut
normal
determin
use
gener
dagostinopearson
test
order
determin
compar
immunogen
differ
form
merscov
protein
construct
five
vector
scheme
target
transgen
genom
shown
fig
express
level
differ
form
merscov
glycoprotein
evalu
western
blot
analysi
fig
sampl
fulllength
glycoprotein
protein
detect
two
polypeptid
fig
upper
band
repres
glycosyl
form
protein
kda
lower
band
kda
repres
subunit
result
sprotein
cleavag
hostcel
proteas
molecular
weight
band
higher
calcul
accord
nucleotid
sequenc
indic
tent
protein
glycosyl
singl
polypeptid
specif
recogn
antibodi
detect
rbd
rbd
rbdg
rbdfc
sampl
fig
molecular
weight
kda
kda
kda
respect
molecular
weight
polypeptid
base
rbd
correspond
calcul
weight
mice
intramuscularli
immun
singl
dose
vp
per
mous
serum
sampl
collect
three
week
immun
titer
antibodi
specif
protein
rbd
analyz
fig
glycoproteinspecif
igg
detect
serum
sampl
mice
control
group
nonimmun
mice
immun
highest
titer
igg
specif
glycoprotein
detect
group
ci
lowest
immunogen
signific
differ
rbdspecif
igg
titer
detect
fig
four
igg
isotyp
known
mice
respons
identif
clearanc
mani
antigen
determin
titer
igg
isotyp
three
week
postimmun
show
four
igg
isotyp
detect
vaccin
anim
fig
isotyp
immun
anim
titer
follow
group
gmt
respect
gmt
respect
gmt
respect
gmt
respect
observ
signific
intergroup
differ
isotyp
titer
follow
vaccin
titer
significantli
lower
group
respect
titer
differ
significantli
group
gmt
respect
henc
accord
find
isotyp
make
greatest
contribut
total
titer
glycoproteinspecif
igg
determin
titer
neutral
antibodi
pseudovirionbas
neutral
assay
show
mice
immun
gener
neutral
antibodi
fig
gmt
respect
signific
differ
psvna
titer
observ
p
group
neutral
antibodi
detect
three
mice
neutral
antibodi
detect
group
intact
anim
henc
result
conduct
experi
show
immun
express
membran
form
glycoprotein
sg
rbdg
lead
gener
neutral
antibodi
postvaccin
cellular
immun
respons
evalu
use
two
method
accord
number
prolifer
cell
accord
product
cell
respons
glycoprotein
restimul
fulllength
merscov
protein
use
restimul
sinc
contain
largest
number
epitop
present
merscov
particl
prolifer
assay
cell
day
postvaccin
fig
leftsid
panel
show
highest
lymphoprolif
activ
observ
group
lowest
one
detect
group
signific
differ
lymphoprolif
respons
cell
group
immun
intact
anim
observ
group
cell
prolifer
assay
fig
rightsid
panel
show
highest
lymphoprolif
respons
observ
group
lowest
one
detect
group
signifi
sspecif
titer
sspecif
titer
sspecif
titer
sspecif
titer
merscov
glycoprotein
restimul
also
show
strongest
cellular
immun
respons
develop
group
anim
immun
fig
secret
increas
compar
intact
cell
respect
current
specif
prophylact
therapeut
agent
middl
east
respiratori
syndrom
world
intens
research
focus
develop
vaccin
diseas
conduct
usa
germani
south
korea
countri
sever
candid
vaccin
base
merscov
glycoprotein
known
recombin
viral
vector
base
recombin
vaccinia
viru
adenoviru
measl
viru
other
dna
vaccin
combin
candid
vaccin
base
dna
recombin
protein
candid
vaccin
base
viruslik
particl
recombin
protein
key
vaccin
develop
antigen
select
develop
vaccin
mer
base
applic
differ
form
merscov
glycoprotein
fulllength
subunit
rbd
main
target
neutral
antibodi
howev
question
still
remain
open
form
choos
develop
effect
vaccin
known
fulllength
glycoprotein
ensur
group
analysi
product
splenocyt
protect
lethal
infect
caus
merscov
anim
howev
author
express
concern
use
fulllength
merscov
vaccin
thu
report
vaccin
base
fulllength
glycoprotein
sever
acut
respiratori
syndrom
sar
coronaviru
like
merscov
belong
genu
betacoronaviru
induc
immunopatholog
lung
vaccin
organ
strong
antibodi
respons
sarscov
glycoprotein
weak
cell
immun
respons
glycoprotein
modif
part
base
fact
receptorbind
domain
glycoprotein
includ
antigen
variou
studi
show
immunogen
subunit
rbd
rbd
fuse
fc
human
rbdfc
studi
focus
protect
drug
base
rbd
subunit
vaccin
show
rbd
vaccin
protect
anim
merscov
despit
high
titer
neutral
antibodi
capabl
block
interact
viru
receptor
cell
surfac
lack
protect
seem
relat
need
develop
cellular
immun
respons
well
need
block
fusion
viral
cell
membran
mediat
subunit
furthermor
applic
subunitbas
vaccin
well
inactiv
one
prevent
emerg
balanc
respons
often
lead
develop
immun
case
mer
develop
lead
lung
immunopatholog
therefor
import
take
account
fact
vaccineinduc
immun
must
develop
antim
vaccin
numer
antigen
base
merscov
glycoprotein
studi
howev
antigen
condit
use
antigen
deliveri
platform
compar
directli
present
studi
direct
comparison
immunogen
five
differ
form
merscov
glycoprotein
condit
carri
use
deliveri
strong
antibodi
mainli
tcell
immun
respons
develop
anim
vaccin
express
variou
form
merscov
glycoprotein
variant
allow
emerg
balanc
respons
one
key
aspect
develop
antim
vaccin
studi
focus
intens
humor
immun
respons
membran
form
rbd
elicit
power
igg
respons
studi
form
also
demonstr
increas
concentr
ifngamma
fold
intact
fig
increas
concentr
media
splenocyt
immun
mice
restimul
recombin
fulllength
merscov
protein
scatter
plot
show
median
ci
increas
fold
chang
product
follow
restimul
group
one
repres
experi
n
micegroup
asterisk
indic
signific
differ
product
cell
taken
vaccin
intact
anim
p
student
ttest
independ
sampl
membran
form
merscov
glycoprotein
stimul
product
neutral
antibodi
investig
cellular
immun
respons
intens
form
fulllength
merscov
glycoprotein
character
strongest
immunogen
sum
find
obtain
studi
suggest
among
studi
form
merscov
glycoprotein
fulllength
glycoprotein
membran
form
rbd
rbdg
promis
candid
inclus
vaccin
immunogen
five
form
merscov
glycoprotein
mice
compar
studi
platform
base
recombin
adenovir
vector
use
antigen
deliveri
studi
yield
follow
result
power
humor
immun
respons
observ
anim
immun
membranebound
form
rbd
membran
form
merscov
glycoprotein
induc
gener
neutral
antibodi
vaccin
mice
signific
cellular
immun
respons
develop
immun
anim
fulllength
glycoprotein
vaccin
mice
develop
vector
elicit
balanc
respons
russian
feder
state
assign
